ACTIVE SUBSTANCE / INN

TRASTUZUMAB-DKST

Brand name(s): OGIVRI
FDA LISTED
PRESCRIPTION
BLA761074
ACTIVE SUBSTANCE
Trastuzumab-Dkst
REGULATORS
FDA
SPONSORS / MAH
MYLAN GMBH
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OGIVRIBLA761074MYLAN GMBHPrescription

FULL INTELLIGENCE ON TRASTUZUMAB-DKST

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →